66587-69-7

Basic information

• Product Name: 5-ACETYL-2,3-DIMETHYLTHIOPHENE
• Synonyms: 5-ACETYL-2,3-DIMETHYLTHIOPHENE;1-(4,5-dimethyl-2-thienyl)Ethanone
• CAS NO: 66587-69-7
• Molecular Formula: C₈H₁₀OS
• Molecular Weight: 154.23
• Mol File: 66587-69-7.mol
• Article Data: 2

Chemical Properties

• Boiling Point: 262.8°Cat760mmHg
• Flash Point: 112.7°C
• Appearance: /
• Density: 1.078g/cm³
• Vapor Pressure: 0.0107mmHg at 25°C
• Refractive Index: 1.532
• CAS DataBase Reference: 5-ACETYL-2,3-DIMETHYLTHIOPHENE(CAS DataBase Reference)
• NIST Chemistry Reference: 5-ACETYL-2,3-DIMETHYLTHIOPHENE(66587-69-7)
• EPA Substance Registry System: 5-ACETYL-2,3-DIMETHYLTHIOPHENE(66587-69-7)

Safety Data

• Hazardous Substances Data: 66587-69-7(Hazardous Substances Data)

Usage

InChI:InChI=1/C8H10OS/c1-5-4-8(6(2)9)10-7(5)3/h4H,1-3H3

Upstream product

• 632-16-6 2,3-dimethylthiophene 
• 108-24-7 acetic anhydride 
• 75-36-5 acetyl chloride 
• 7646-78-8 tin(IV) chloride 
• 5895-88-5 3-methyl-thiophene-2-carbaldehyde semicarbazone 
• 5834-16-2 3-methyl-2-thiophenecarboxaldehdye 

Downstream Products

• 399043-52-8 N-[3-(3-bromo-benzoyl)-4,5-dimethyl-thiophen-2-yl]-acetamide 
• 399043-53-9 N-[4,5-dimethyl-3-(3-methyl-benzoyl)-thiophen-2-yl]-acetamide 
• 399043-50-6 N-[3-(3-fluoro-benzoyl)-4,5-dimethyl-thiophen-2-yl]-acetamide 
• 399043-51-7 N-[3-(3-chloro-benzoyl)-4,5-dimethyl-thiophen-2-yl]-acetamide 
• 399043-19-7 (4,5-dimethyl-2-methylcarbamoyl-thiophen-3-yl)(phenyl)methanone 
• 132861-87-1 PD 81723 

Relevant articles and documents

2-amino-3-aroyl-4,5 alkylthiophenes: agonist allosteric enhancers at human A1 adenosine receptors

The present invention relates to a compound of formula (I): wherein: R3 is selected from the group consisting of 1-napthyl, 2-napthyl and cycloalkylphenyl; and R4 and R5 taken together form a ring having from 5 to 10 carbon atoms. Additionally, the invention provides a therapeutic method for preventing or treating a pathological condition or symptom in a mammal subject, such as a human, wherein increased angiogenesis is desired, comprising administering to a mammal in need of such therapy an effective amount of the aforementioned thiophene selective adenosine A1 allosteric enhancer.